📰 Affymax News
Affymax News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Affymax. Real-time updates on events, politics, business and more.
September 25, 2023
(RTTNews) - Biotechnology company Jasper Therapeutics, Inc. (JSPR) announced Monday the appointment of Herb Cross, an experienced senior financial...
May 3, 2023
Merus (NASDAQ:MRUS – Get Rating) and Affymax (OTCMKTS:AFFY – Get Rating) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, dividends, risk, profitability, analyst recommendations, earnings and institutional ownership. Valuation & Earnings This table compares Merus and Affymax’s revenue, earnings per […]
September 13, 2022
The proprietary platform is versatile, equally effective with different cargoes, routes of administration
August 25, 2022
SOUTH SAN FRANCISCO, Calif., Aug. 25, 2022 (GLOBE NEWSWIRE) -- Frontier Medicines Corporation, a precision medicine company seeking to unlock the...
August 25, 2022
Frontier Medicines Announces the Appointment of Seasoned Legal Executive Mark Dizon, J.D., as General Counsel - read this article along with other careers information, tips and advice on BioSpace
August 19, 2022
CAMBRIDGE, Mass., Aug. 15, 2022 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the field of cellular metabolism pioneering...
June 21, 2022
/PRNewswire/ -- The "Global Genitourinary Partnering 2010-2022: Deal Trends, Players and Financials" report has been added to ResearchAndMarkets.coms offering....
April 23, 2022
Benitec Biopharma (NASDAQ:BNTC – Get Rating) and Affymax (OTCMKTS:AFFY – Get Rating) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, valuation, dividends, analyst recommendations and risk. Institutional and Insider Ownership 20.2% of Benitec Biopharma shares are owned […]
April 28, 2021
Alladapt Immunotherapeutics Inc., a private, clinical-stage biopharmaceutical company focused on the development of prescription therapeutics to address
January 20, 2021
Press release content from Globe Newswire. The AP news staff was not involved in its creation. T-knife Announces Appointment of Thomas M. Soloway as Chief Executive Officer and Camille A. ... AKAMPIONJanuary 19, 2021 GMT San Francisco, CA / Berlin, Germany – January 19, 2021 — T-knife GmbH, a next-generation adoptive T-cell therapy company leveraging its proprietary humanized T-cell receptor (HuTCR) mouse platform to treat solid tumors, today announced the appointment of Thomas M. Soloway a...